Role of the phosphatidylinositol 3-kinase/protein kinase B pathway in regulating alternative splicing of tissue factor mRNA in human endothelial cells

Circulation Journal

Volumn 73, Issue 9, 2009, Pages 1746-1752

  Eisenreich, Andreas ^a   Malz, Ronny ^a   Pepke, Wojciech ^a   Ayral, Yunus ^a   Poller, Wolfgang ^a   Schultheiss, Heinz Peter ^a   Rauch, Ursula ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Cytokines; Endothelial function; Inflammation; Kinase; Thrombosis

Indexed keywords

ARGININE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; POLYHISTIDINE TAG; PROTEIN KINASE B; SERINE; THROMBOPLASTIN;

ALTERNATIVE RNA SPLICING; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INHIBITION KINETICS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; THROMBOGENICITY; TRANSCRIPTION REGULATION; WESTERN BLOTTING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ALTERNATIVE SPLICING; CELLS, CULTURED; CHROMONES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; HUMANS; MORPHOLINES; NF-KAPPA B; NITRILES; NUCLEAR PROTEINS; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-AKT; RNA, MESSENGER; RNA-BINDING PROTEINS; SIGNAL TRANSDUCTION; SULFONES; THROMBOPLASTIN; TIME FACTORS; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 69549086152     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-99-0225     Document Type: Article

References (37)

1. Giesen PL, Rauch U, Bohrman B, Kling D, Roque, Fallon JT, et al. Blood-borne tissue factor: Another view of thrombosis. Proc Natl Acad Sci USA 1999; 96: 2311-2315. (Pubitemid 29117911)
2. Szotowski B, Antoniak S, Rauch U. Alternatively spliced tissue factor: A previously unknown piece in the puzzle of hemostasis. Trends Cardiovasc Med 2006; 16: 177-182. (Pubitemid 43867331)
3. Rauch U, Bonderman D, Bohrmann B, Badimon JJ, Himber J, Riederer MA, et al. Transfer of tissue factor from leukocytes to platelets is mediated by CD 15 and tissue factor. Blood 2000; 96: 170-175. (Pubitemid 30456467)
4. Mackman N. Role of tissue factor in hemostasis, thrombosis, and vascular development. Arterioscler Thromb Vasc Biol 2004; 24: 1015-1022. (Pubitemid 38737825)
5. Rauch U, Nemerson Y. Circulating tissue factor and thrombosis. Curr Opin Hematol 2000; 7: 273-277.
6. Szotowski B, Antoniak S, Poller W, Schultheiss HP, Rauch U. Procoagulant soluble tissue factor is released from endothelial cells in response to inflammatory cytokines. Circ Res 2005; 96: 1233-1239. (Pubitemid 40962100)
7. Morel O, Toti F, Hugel B, Bakouboula B, Camoin-Jau L, Dignat-George F, et al. Procoagulant microparticles: Disrupting the vascular homeostasis equation? Arterioscler Thromb Vasc Biol 2006; 26: 2594-2604.
8. Bobbert P, Antoniak S, Schultheiss HP, Rauch U. Globular adiponectin but not full-length adiponectin induces increased procoagulability in human endothelial cells. J Mol Cell Cardiol 2008; 44: 388-394. (Pubitemid 351226195)
9. Kasuya N, Kishi Y, Isobe M, Yoshida M, Numano F. P-selectin expression, but not GPIIb/IIIa activation, is enhanced in the inflammatory stage of Takayasu's arteritis. Circ J 2006; 70: 600-604.
10. Eisenreich A, Bogdanov VY, Zakrzewicz A, Pries A, Antoniak S, Poller W, et al. Cdc2-like kinases and DNA topoisomerase I regulate alternative splicing of tissue factor in human endothelial cells. Circ Res 2009; 104: 589-599.
11. Szotowski B, Antoniak S, Goldin-Lang P, Tran QV, Pels K, Rosenthal P, et al. Antioxidative treatment inhibits the release of thrombogenic tissue factor from irradiation- and cytokine-induced endothelial cells. Cardiovasc Res 2007; 73: 806-812. (Pubitemid 46227358)
12. Bogdanov VY, Balasubramanian V, Hathcock J, Vele O, Lieb M, Nemerson Y. Alternatively spliced human tissue factor: A circulating, soluble, thrombogenic protein. Nat Med 2003; 9: 458-462. (Pubitemid 36460081)
13. Yu JL, Rak JW. Shedding of tissue factor (TF)-containing microparticles rather than alternatively spliced TF is the main source of TF activity released from human cancer cells. J Thromb Haemost 2004; 2: 2065-2067.
14. Bogdanov VY. Blood coagulation and alternative pre-mRNA splicing: An overview. Curr Mol Med 2006; 6: 859-869.
15. Hobbs JE, Zakarija A, Cundiff DL, Doll JA, Hymen E, Cornwell M, et al. Alternatively sphced human tissue factor promotes tumor growth and angiogenesis in a pancreatic cancer tumor model. Thromb Res 2007; 120(Suppl 2): S13-S21. (Pubitemid 350101769)
16. Black DL. Mechanisms of alternative pre-messenger RNA splicing. Annu Rev Biochem 2003; 72: 291-336. (Pubitemid 36930448)
17. Bourgeois CF, Lejeune F, Stévenin J. Broad specificity of SR (serine/arginine) proteins in the regulation of alternative splicing of pre-messenger RNA. Prog Nucleic Acids Res Mol Biol 2004; 78: 37-88. (Pubitemid 39753917)
18. Jiang K, Patel NA, Watson JE, Apostolatos H, Kleiman E, Hanson O, et al. Akt2 regulation of Cdc2-like kinases (Clk/Sty), serine/arginine-rich (SR) protein phosphorylation, and insulin-induced alternative splicing of PKCssII mRNA. Endocrinology 2009; 150: 2087-2097.
19. Stamm S. Regulation of alternative splicing by reversible protein phosphorylation. J Biol Chem 2008; 283: 1223-1227.
20. Prasad J, Colwill K, Pawson T, Manley JL. The protein kinase Clk/Sty directly modulates SR protein activity: Both hyper- and hypophosphorylation inhibit splicing. Mol Cell Biol 1999; 19: 6991-7000. (Pubitemid 29441881)
21. Huang CJ, Tang Z, Lin RJ, Tucker PW. Phosphorylation by SR kinases regulates the binding of PTB-associated splicing factor (PSF) to the pre-mRNA polypyrimidine tract. FEBS Lett 2007; 581: 223-232. (Pubitemid 46110829)
22. Blaustein M, Pelisch F, Tanos T, Muñoz MJ, Wengier D, Quadrana L. Concerted regulation of nuclear and cytoplasmic activities of SR proteins by AKT. Nat Struct Mol Biol 2005; 12: 1037-1044. (Pubitemid 41746773)
23. Liu X, Mayeda A, Tao M, Zheng ZM. Exonic splicing enhancer-dependent selection of the bovine papillomavirus type 1 nucleotide 3225 3′ splice site can be rescued in a cell lacking splicing factor ASF/SF2 through activation of the phosphatidylinositol 3-kinase/Akt pathway. J Virol 2003; 77: 2105-2115. (Pubitemid 36110023)
24. Patel NA, Kaneko S, Apostolatos HS, Bae SS, Watson JE, Davidowitz K. Molecular and genetic studies imply Akt-mediated signaling promotes protein kinase CbetaII alternative splicing via phosphorylation of serine/arginine-rich splicing factor SRp40. J Biol Chem 2005; 280: 14302-14309. (Pubitemid 40517333)
25. Szotowski B, Goldin-Lang P, Antoniak S, Bogdanov VY, Pathirana D, Pauschinger M. Alterations in myocardial tissue factor expression and cellular localization in dilated cardiomyopathy. J Am Coll Cardiol 2005; 45: 1081-1089. (Pubitemid 40432443)
26. Eisenreich A, Celebi Ö, Goldin-Lang P, Schultheiss HP, Rauch U. Upregulation of tissue factor expression and thrombogenic activity in human aortic smooth muscle cells by irradiation, rapamycin and paclitaxel. Int Immunopharmacol 2008; 8: 307-311.
27. Seimi SK, Seinosuke K, Tsuyoshi S, Tomomi U, Tetsuaki H, Miki K, et al. Glycogen synthase kinase-3β is involved in the process of myocardial hypertrophy stimulated by insulin-like growdi factor-1. Circ J 2004; 68: 247-253.
28. Radhakrishnan G, Suzuki R, Maeda H, Yamamoto M, Hirose N, Gopalrao RK, et al. Inhibition of neointimal hyperplasia development by MCI-186 is correlated with downregulation of nuclear factor-κB pathway. Circ J 2008; 72: 800-806. (Pubitemid 351716686)
29. Eisenreich A, Boltzen U, Poller W, Schultheiss HP, Rauch U. Effects of the Cdc2-like kinase-family and DNA topoisomerase I on the alternative splicing of eNOS in TNF-α-stimulated human endothelial cells. Biol Chem 2008; 389: 1333-1338.
30. Matsumoto R, Yoshiyama M, Omura T, Kim S, Nakamura Y, Izumi Y, et al. Effects of aldosterone receptor antagonist and angiotensin II type I receptor blocker on cardiac transcriptional factors and mRNA expression in rats with myocardial infarction. Circ J 2004; 68: 376-382. (Pubitemid 38470715)
31. Wang L, Wei W, Hu Y, Song S, Yan Z. An oligonucleotide decoy for nuclear factor-kappa B inhibits tumor necrosis factor-alpha-induced human umbilical cord vein endothelial cell tissue factor expression in vitro. Blood Coagul Fibrinolysis 2004; 15: 483-490. (Pubitemid 39180233)
32. Goldin-Lang P, Pels K, Tran QV, Szotowski B, Wittchen F, Antoniak S, et al. Effect of ionizing radiation on cellular procoagulability and co-ordinated gene alterations. Haematologica 2007; 92: 1091-1098. (Pubitemid 350144216)
33. Walsh K. Adipokines, myokines and cardiovascular disease. Circ J 2009; 73: 13-18.
34. Goldin-Lang P, Tran QV, Fichtner I, Eisenreich A, Antoniak S, Schulze K, et al. Tissue factor expression pattern in human non-small cell lung cancer tissues indicate increased blood thrombogenicity and tumor metastasis. Oncol Rep 2008; 20: 123-128.
35. Niwa Y, Iwai N. Nanomaterials induce oxidized low-density lipoprotein cellular uptake in macrophages and platelet aggregation. Circ J 2007; 71: 437-444. (Pubitemid 46409551)
36. Tardos JG, Eisenreich A, Deikus G, Bechhofer DH, Chandradas S, Zafar U, et al. SR proteins ASF/SF2 and SRp55 participate in tissue factor biosynthesis in human monocytic cells. J Thromb Haemost 2008; 6: 877-884.
37. Satoh E, Ono K, Xu F, Iijima T. Cloning and functional expression of a novel splice variant of rat TRPC4. Circ J 2002; 66: 954-958.